Discounted Cash Flow (DCF) Analysis Unlevered
Akzo Nobel N.V. (AKZA.AS)
71.7 €
+0.56 (+0.79%)
All numbers are in Millions, Currency in USD
Operating Data
Year A/P | 2018 Actual | 2019 Actual | 2020 Actual | 2021 Actual | 2022 Actual | 2023 Projected | 2024 Projected | 2025 Projected | 2026 Projected | 2027 Projected |
Revenue | 9,256 | 9,276 | 8,530 | 9,587 | 10,846 | 11,325.87 | 11,826.98 | 12,350.26 | 12,896.69 | 13,467.29 |
---|---|---|---|---|---|---|---|---|---|---|
Revenue (%) | ||||||||||
EBITDA | 907 | 1,259 | 1,377 | 1,530 | 1,076 | 1,481.30 | 1,546.84 | 1,615.28 | 1,686.75 | 1,761.38 |
EBITDA (%) | ||||||||||
EBIT | 668 | 899 | 1,016 | 1,179 | 708 | 1,079.25 | 1,127 | 1,176.86 | 1,228.93 | 1,283.30 |
EBIT (%) | ||||||||||
Depreciation | 239 | 360 | 361 | 351 | 368 | 402.05 | 419.84 | 438.42 | 457.82 | 478.07 |
Depreciation (%) |
Balance Sheet Data
Year A/P | 2018 Actual | 2019 Actual | 2020 Actual | 2021 Actual | 2022 Actual | 2023 Projected | 2024 Projected | 2025 Projected | 2026 Projected | 2027 Projected |
Total Cash | 8,248 | 1,401 | 1,856 | 1,210 | 1,786 | 3,512.38 | 3,667.78 | 3,830.06 | 3,999.52 | 4,176.47 |
---|---|---|---|---|---|---|---|---|---|---|
Total Cash (%) | ||||||||||
Account Receivables | 2,152 | 2,156.65 | 1,983.21 | 2,228.96 | 2,521.67 | 2,633.24 | 2,749.75 | 2,871.41 | 2,998.45 | 3,131.12 |
Account Receivables (%) | ||||||||||
Inventories | 1,139 | 1,139 | 1,159 | 1,650 | 1,843 | 1,639.42 | 1,711.96 | 1,787.70 | 1,866.80 | 1,949.39 |
Inventories (%) | ||||||||||
Accounts Payable | 1,843 | 1,883 | 2,032 | 2,376 | 2,206 | 2,472.57 | 2,581.97 | 2,696.20 | 2,815.50 | 2,940.07 |
Accounts Payable (%) | ||||||||||
Capital Expenditure | -160 | -214 | -258 | -288 | -292 | -288.96 | -301.74 | -315.09 | -329.03 | -343.59 |
Capital Expenditure (%) |
Weighted Average Cost Of Capital
Share price | $ 71.7 |
---|---|
Beta | 1.035 |
Diluted Shares Outstanding | 185.67 |
Cost of Debt | |
Tax Rate | 41.53 |
After-tax Cost of Debt | 2.43% |
Risk-Free Rate | |
Market Risk Premium | |
Cost of Equity | 9.041 |
Total Debt | 5,875 |
Total Equity | 13,312.82 |
Total Capital | 19,187.82 |
Debt Weighting | 30.62 |
Equity Weighting | 69.38 |
Wacc |
Build Up Free Cash
Year A/P | 2018 Actual | 2019 Actual | 2020 Actual | 2021 Actual | 2022 Actual | 2023 Projected | 2024 Projected | 2025 Projected | 2026 Projected | 2027 Projected |
Revenue | 9,256 | 9,276 | 8,530 | 9,587 | 10,846 | 11,325.87 | 11,826.98 | 12,350.26 | 12,896.69 | 13,467.29 |
---|---|---|---|---|---|---|---|---|---|---|
EBITDA | 907 | 1,259 | 1,377 | 1,530 | 1,076 | 1,481.30 | 1,546.84 | 1,615.28 | 1,686.75 | 1,761.38 |
EBIT | 668 | 899 | 1,016 | 1,179 | 708 | 1,079.25 | 1,127 | 1,176.86 | 1,228.93 | 1,283.30 |
Tax Rate | -1,064.75% | 31.34% | 31.45% | 24.98% | 41.53% | -187.09% | -187.09% | -187.09% | -187.09% | -187.09% |
EBIAT | 7,780.51 | 617.28 | 696.50 | 884.52 | 413.98 | 3,098.42 | 3,235.51 | 3,378.66 | 3,528.15 | 3,684.25 |
Depreciation | 239 | 360 | 361 | 351 | 368 | 402.05 | 419.84 | 438.42 | 457.82 | 478.07 |
Accounts Receivable | - | -4.65 | 173.44 | -245.75 | -292.71 | -111.57 | -116.51 | -121.66 | -127.04 | -132.66 |
Inventories | - | 0 | -20 | -491 | -193 | 203.58 | -72.54 | -75.74 | -79.10 | -82.60 |
Accounts Payable | - | 40 | 149 | 344 | -170 | 266.57 | 109.40 | 114.24 | 119.29 | 124.57 |
Capital Expenditure | -160 | -214 | -258 | -288 | -292 | -288.96 | -301.74 | -315.09 | -329.03 | -343.59 |
UFCF | 7,859.51 | 798.63 | 1,101.94 | 554.77 | -165.73 | 3,570.10 | 3,273.97 | 3,418.82 | 3,570.08 | 3,728.04 |
WACC | ||||||||||
PV UFCF | 3,335.91 | 2,858.54 | 2,789.21 | 2,721.57 | 2,655.56 | |||||
SUM PV UFCF | 14,360.79 |
Terminal Value
Growth in perpetuity method: | |
---|---|
Long-term growth rate | |
WACC (%) | 7.02 |
Free cash flow (t + 1) | 3,802.60 |
Terminal Value | 75,749.04 |
Present Value of Terminal Value | 53,957.57 |
Intrinsic Value
Enterprise Value | 68,318.36 |
---|---|
Net Debt | 4,425 |
Equity Value | 63,893.36 |
Shares Outstanding | 185.67 |
Equity Value Per Share | 344.12 |